Sponsor
Arvinas Androgen Receptor Inc.
5 Science Park, 06511-1966, United States
About the sponsor
Arvinas Androgen Receptor Inc. is involved in clinical research for metastatic prostate cancer, with a clear focus on treatment options for advanced disease. Its funded work centers on therapies that target androgen receptor-driven cancer biology and disease progression.
- Metastatic prostate cancer
- Androgen receptor-targeted therapy
- Advanced solid tumour treatment
The sponsor’s research activity in this area reflects interest in therapeutic strategies for patients with progressive prostate malignancy, including combinations used in hormone-sensitive and castration-resistant settings.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.